Global Glucose Monitoring Market Forecast to 2025 – Increasing Demand for Less Invasive Devices – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Glucose
Monitoring Global Market Report – Forecast to 2025” report has
been added to ResearchAndMarkets.com’s offering.

The market is focused on growing with newer technology and improved
products.

Factors driving the Glucose Monitoring market are a global rise in the
prevalence and incidence of diabetes, continuous technological
advancement, increasing demand for less invasive products, and an
increase in R&D investments that are driving the market growth. An
increase in the obesity population due to lifestyle changes, an increase
in urbanization, untapped markets like the Middle East, Africa shows
that the glucose monitoring market has vast opportunities in the coming
years.

Frequent product recalls i.e. glucose testing strips due to
manufacturing defects or supply of expired test strips and less product
differentiation among the self blood glucose monitors are the factors
that are restraining the market growth. The limited reimbursement
facilities and alternative treatments that include cell-based assays,
biomarkers identification, and artificial pancreas and high cost
associated with Continuous Glucose Monitoring (CGM) are threats for the
market growth.

Glucose Monitoring global market is classified based on products, sample
type, end-users, and geography. The product segment is divided into
three segments i.e., Invasive, Non-Invasive and lab-based glucose
monitoring products. The Invasive glucose monitoring products segment
accounted for the largest share in 2018 and is projected to grow at a
low single-digit CAGR from 2018 to 2025 due to technological
advancements, easy use, patient-friendly, etc. Invasive products are
classified into Self glucose monitoring and continuous glucose products.
The self glucose monitoring segment accounted for the largest share in
2018 due to the development of minimally invasive products.

The Self glucose monitoring products are further classified into blood
glucose monitors, blood glucose test strips, lancets and others. The
blood glucose testing strips segment accounted for the largest share in
2018 due to the development of no coding strips. The continuous glucose
monitoring market includes sensors/receivers and transmitters. The
continuous glucose market includes products sensors/receivers and
transmitters. The continuous glucose segment is the fastest growing
segment and is projected to grow at a strong double-digit CAGR from 2018
to 2025.

Based on sample type the market is segmented into blood, urine, and
others. The blood segment accounted for the largest share in 2018 due to
the accuracy of results. Other source based glucose monitoring segment
is the fastest growing segment and is projected to grow exponentially
from 2018 to 2025 due to increases R&D investment, many products are CE
approved and expected launch very soon in the market.

Based on end users the market is segmented into hospitals, private
clinics, home care, and ambulatory settings. Among end-users, home care
segment accounted for the largest share in 2018 and is projected to grow
at a low single-digit CAGR from 2018 to 2025 due to the availability of
over the counter (OTC) self blood glucose monitor and ease in operating
these monitors and thereby reducing the frequent visits to hospitals or
clinics for checking glucose levels.

The steep rise in the aging population, advancement in technology,
awareness of people about treatment options and favorable government
policies are driving factors of the glucose monitoring market. However,
Asian countries especially India and China are the fastest growing
regions with its growing demand for glucose monitoring products.

Key Topics Covered:

1 Executive Summary

2 Introduction

2.1 Key Takeaways

2.2 Report Description

2.3 Markets Covered

2.4 Stakeholders

2.5 Research Methodology

2.5.1 Market Size Estimation

2.5.2 Market Breakdown and Data Triangulation

2.5.3 Secondary Sources

2.5.4 Primary Sources

2.5.5 Key Data Points from Secondary Sources

2.5.6 Key Data Points from Primary Sources

2.5.7 Assumptions

3 Market Analysis

3.1 Introduction

3.2 Market Segmentation

3.3 Factors Influencing Market

3.3.1 Drivers and Opportunities

3.3.1.1 The Global Rise in The Prevalence and Incidence of Diabetes

3.3.1.2 Technological Advancements in Glucose Monitoring Devices

3.3.1.3 Increasing Demand for Less Invasive Devices or Point of Care

3.3.1.4 Increasing R & D Investments

3.3.2 Restraints and Threats

3.3.2.1 Availability of Alternative Treatment

3.3.2.2 High Cost Associated With the Products

3.3.2.3 Inadequate Reimbursement

3.3.2.4 Product Recalls

3.3.2.5 Strict Regulation of Glucose Monitoring Devices by Regulatory
Organizations Like the Fda and Others.

3.4 Regulatory Affairs

3.4.1 U.S.

3.4.2 Europe

3.4.3 China

3.4.4 India

3.4.5 Japan

3.5 Reimbursement Scenario

3.6 Patent Analysis

3.7 Technology Advancements

3.7.1 Artificial Intelligence and Radar Technology

3.7.2 Non-Invasive Continuous Glucose Monitoring Wearable

3.7.3 Tear Glucose Monitoring Technology

3.7.4 Saliva-Based Biosensors

3.7.5 Micro-needle Patch

3.7.6 Photothermal Detection of Glucose Levels

3.8 Product Launches and Approvals

3.9 Funding Scenario

3.10 Glucose Monitoring – Deals

3.11 Clinical Trial Data

3.12 Porter’s Five Force Analysis

3.13 Supply Chain Analysis

3.14 Market Share Analysis by Major Players

3.14.1 Glucose Monitoring Global Market Share Analysis

3.14.2 Self Blood Glucose Monitoring Global Market Share

3.14.3 Continuous Glucose Monitoring Global Market

4 Glucose Monitoring Global Market, by Products

4.1 Introduction

4.2 Invasive Glucose Monitoring

4.2.1 Self Glucose Monitoring

4.2.1.1 Blood Glucose Meter

4.2.1.2 Blood Glucose Testing Strips

4.2.1.3 Lancets

4.2.1.4 Others

4.2.2 Continuous Glucose Monitoring

4.2.2.1 Glucose Sensors

4.2.2.2 Transmitters and Receivers

4.3 Non-Invasive Glucose Monitoring

4.4 Lab Based Glucose Monitoring

5 Glucose Monitoring Global Market, by Sample Source

5.1 Introduction

5.2 Blood-Based Glucose Monitoring

5.3 Urine-Based Glucose Monitoring

5.4 Other Sources Based Glucose Monitoring

6 Glucose Monitoring Global Market, by End-Users

6.1 Introduction

6.2 Hospitals

6.3 Home Care

6.4 Private Clinics

6.5 Ambulatory Settings

7 Regional Analysis

8 Competitive Landscape

8.1 Introduction

8.2 New Product Launches

8.3 Collaboration & Partnerships

8.4 Other Developments

9 Major Companies

9.1 Abbott Laboratories, Inc

9.1.1 Overview

9.1.2 Financials

9.1.3 Product Portfolio

9.1.4 Key Developments

9.1.5 Business Strategy

9.1.6 SWOT Analysis

9.2 Arkray, Inc.

9.3 Ascensia Diabetes Care Holdings AG.

9.4 B.Braun Melsungen AG

9.5 Bio-Rad Laboratories

9.6 Dexcom, Inc.

9.7 LifeScan (Johnson & Johnson)

9.8 Medtronic, Plc

9.9 Sinocare Inc.

9.10 Roche Holdings AG

Other Companies Mentioned

• A&T Corporation
• Abbott Laboratories
• Acon Diabetes Care International
• Adaltis
• Agamatrix Inc
• Alliance International
• Allmedicus
• Ambrosia Systems
• Andon Health Co Ltd
• Apex Biotechnology Corp
• Arkray
• Ascensia Diabetes Care
• B.Braun
• Becton Dickinson
• Beijing Yicheng Bioelectronics Technology Co., Ltd.
• Beurer Gmbh
• Bio-Rad Laboratories
• Biochemical Systems International
• Bioland Technology
• Bionime Corporation
• Bioptik Technology
• Biotelemetry Inc
• Biotest Medical Corporation
• Bodytel Gmbh
• Bremed Limited
• Cambridge Sensors
• Carematix Inc
• Ceragem Medisys Inc.
• Chungdo Pharm. Co., Ltd
• Contec Medical Systems
• Convergent Technologies
• Danaher
• Dario
• Delbio Incorporation
• Dexcom, Inc
• Diabetomics, Inc
• Diamontech
• Echo Therapeutics
• Ekf Diagnostics
• Emsig Gmbh Co
• Entra Health Systems Llc
• Eps Biotechnology Corp.
• Erba Diagnostics
• Eser Digital
• Evia Medical Technologies
• Fia Biomed Gmbh
• Fora Care, Inc
• GE
• General Life Biotechnology
• Genesis Health Technologies
• Glooko
• Gluco Rx
• Glucostratus Ltd
• Glysens Incorporated
• Glysure Limited
• Hangzhou Sejoy Electronics & Instruments
• Hemocue Ab
• Hmd Biomedical
• Hubdic Co Ltd
• Hygeia, Inc.
• I-Sens
• Ideal Life Inc.
• Ihealth Labs Inc
• Ime-Dc Gmbh
• In4 Technology Corp
• Infopia Co Ltd
• Inside Biometrics
• Insulet Corporation
• Integrity Applications
• International Biomedical
• Intuity Medical, Inc
• Ixensor Company Ltd.
• Jiangsu Yuyue Medical Equipment & Supply Co., Ltd
• K-Jump Health Co., Ltd
• L-Tac Medicare
• Life Plus
• Lifotronic
• Light Touch Medical Inc
• Lobeck Medical Ag
• Medisana
• Mediwise
• Medtronic Plc
• Menarini Group
• Mico Nanobiosys Ltd
• National Diagnostic Products
• Nemaura Medical Inc
• Nipro
• Nova Biomedical
• Noviosense
• Ok Biotech Co. Ltd
• Omron Healthcare
• Osang Health Care Co Ltd
• Palmdoc
• Pendiq
• Pepex Biomedical
• Pharma Tech Solutions Inc
• Philosys Inc
• Platinum Equity (Life Scan Inc)
• Prediktor Medical
• Prodigy Diabetes Care, Llc
• Roche Diagnostics
• Romed Holland
• Sanofi
• Sd Biosensor
• Senseonics
• Sinocare
• Sorrento Biochemical, Inc.
• Stairway Laboratories Inc
• Syn-Kit, Inc.
• Taidoc Technology Corporation
• Tandom Diabetes Care
• Terumo
• Thermo Fisher Scientific
• Tianjin Empecs Medical Device Co., Ltd.
• Tosoh Corporation
• Trinity Biotech
• Truly Instrument Limited
• Tyson Bioresearch Inc
• Visgeneer Inc
• Vivachek Laboratories, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/5aycpi

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Glucose
Testing, Diabetes
Devices